Top Suppliers:I want be here

  • DC Chemicals Limited
  • China
  • Product Name: PMEDAP
  • Price: $Inquiry/100mg ¥Inquiry/250mg ¥Inquiry/1g
  • Purity: 98.0%
  • Stocking Period: 1 Day
  • Contact: Tony Cao

113852-41-8

113852-41-8 structure
113852-41-8 structure
  • Name: PMEDAP
  • Chemical Name: 2-(2,6-diaminopurin-9-yl)ethoxymethylphosphonic acid
  • CAS Number: 113852-41-8
  • Molecular Formula: C8H13N6O4P
  • Molecular Weight: 288.20
  • Catalog: Signaling Pathways Anti-infection CMV
  • Create Date: 2016-12-26 12:18:10
  • Modify Date: 2024-01-13 21:41:02
  • PMEDAP is a potent inhibitor of human immunodeficiency virus (HIV) replication. PMEDAP has anti-murine cytomegalovirus (MCMV) activity. PMEDAP is a very potent inhibitor of Moloney murine sarcoma virus (MSV)-induced tumor formation and associated mortality[1][2].

Name 2-(2,6-diaminopurin-9-yl)ethoxymethylphosphonic acid
Synonyms {[2-(2,6-diamino-9h-purin-9-yl)ethoxy]methyl}phosphonic acid
N-(2-Phosphonomethoxyethyl)-2,6-diaminopurine
9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine
9-(2-phosphonomethoxyethyl)-2,6-diaminopurine
2,6-diamino-9-[2-(phosphonomethoxy)ethyl]purine
5-(3-Hydroxy-2-phosphonomethoxypropyladenine)
PME-DAP
Phosphonic acid,((2-(2,6-diamino-9H-purin-9-yl)ethoxy)methyl)
PMEDAP
Description PMEDAP is a potent inhibitor of human immunodeficiency virus (HIV) replication. PMEDAP has anti-murine cytomegalovirus (MCMV) activity. PMEDAP is a very potent inhibitor of Moloney murine sarcoma virus (MSV)-induced tumor formation and associated mortality[1][2].
Related Catalog
In Vivo PMEDAP (0.25-5 mg/kg; IP; daily; starting on the day of MSV-infected and continuing for an additional four days) causes a dose-dependent suppression of tumor formation and mortality in newborn mice inoculated with MSV[1]. Animal Model: Three-week-old male NMRI mice[1] Dosage: 0.25 mg/kg, 1 mg/kg, 5 mg/kg Administration: IP; daily; starting on the day of infection and continuing for an additional four days Result: Effected a significant delay in tumor appearance and an enhancement of the survival rate of tumor-bearing mice.
References

[1]. Neyts J, et al. Activity of the anti-HIV agent 9-(2-phosphonyl-methoxyethyl)-2,6-diaminopurine against cytomegalovirus in vitro and in vivo [published correction appears in Eur J Clin Microbiol Infect Dis 1993 Jul;12(7):following 477]. Eur J Clin Microbiol Infect Dis. 1993;12(6):437-446.

[2]. Naesens L, et al. 9-(2-Phosphonylmethoxyethyl)-2,6-diaminopurine (PMEDAP): a novel agent with anti-human immunodeficiency virus activity in vitro and potent anti-Moloney murine sarcoma virus activity in vivo. Eur J Clin Microbiol Infect Dis. 1989;8(12):1043-1047.

Density 2.03g/cm3
Boiling Point 748.7ºC at 760mmHg
Molecular Formula C8H13N6O4P
Molecular Weight 288.20
Flash Point 406.6ºC
Exact Mass 288.07400
PSA 172.94000
Vapour Pressure 1.51E-23mmHg at 25°C
Index of Refraction 1.826
Hazard Codes Xi